| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2 | 0.599 | 0.615 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
phosphatidylinositol glycan anchor biosynthesis class K | 0.839 | 0.154 | 1.4E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
microRNA 711 | 0.751 | 0.269 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
immunoglobulin lambda like polypeptide 5 | 0.769 | 0.462 | 5.2E-10 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
InaF motif containing 2 | 0.890 | 0.115 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
structural maintenance of chromosomes 4 | 0.678 | 0.346 | 1.7E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
RBM14-RBM4 readthrough | 0.647 | 0.615 | 0.98 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
BCL2L2-PABPN1 readthrough | 0.653 | 0.500 | 0.28 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
endogenous retrovirus group K member 18 | 0.560 | 0.654 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | |||||||||
|
myelinating Schwann cell element | 0.821 | 0.231 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | |||||||||
|
nicotinamide phosphoribosyltransferase | 0.502 | 0.808 | 0.98 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
ROR1 antisense RNA 1 | 0.751 | 0.192 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | |||||||||
|
cyclin dependent kinase 7 | 0.566 | 0.731 | 4.5E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
microRNA 7977 | 0.769 | 0.346 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
sprouty RTK signaling antagonist 2 | 0.554 | 0.654 | 0.97 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
cyclin dependent kinase inhibitor 1C | 0.456 | 0.846 | 0.82 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
tumor protein p53 pathway corepressor 1 | 0.628 | 0.500 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
deleted in lymphocytic leukemia 1 | 0.569 | 0.692 | 0.47 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1986 | 1986 | ||||||||
|
trafficking from ER to golgi regulator | 0.595 | 0.615 | 0.14 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
cysteine dioxygenase type 1 | 0.592 | 0.654 | 9.7E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
Kruppel like factor 2 | 0.542 | 0.692 | 0.56 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
craniofacial development protein 1 | 0.619 | 0.615 | 3.7E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
CD52 molecule | 0.615 | 0.500 | 0.40 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
RNA binding motif protein 14 | 0.628 | 0.615 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
nuclear RNA export factor 1 | 0.531 | 0.885 | 0.98 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 |